Sponsor or institution
Clinical trials and research at Immunovant Sciences GmbH
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Immunovant Sciences GmbH that are recruiting, at sites in 39 countries (most in Italy (4), Poland (4), Spain (4)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 39Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| IMVT-1402 for adults with mild to severe generalized myasthenia gravis. | Phase 3 | Huntsville, Alabama and 87 other locations | Recruiting | Jun 26, 2025 |
| Imeroprubart for adults with CIDP | Phase 2 | Tucson, Arizona and 141 other locations | Recruiting | Jun 24, 2025 |
| IMVT-1402 as a treatment for adults with Graves' disease | Phase 2 | Tucson, Arizona and 162 other locations | Recruiting | Jun 12, 2025 |
| Assessing IMVT-1402 for treating Graves' disease in adults | Phase 2 | Phoenix, Arizona and 133 other locations | Recruiting | Dec 11, 2024 |
All recruiting trials (4)
-
IMVT-1402 for adults with mild to severe generalized myasthenia gravis.
This trial will test whether IMVT-1402 helps adults with mild to severe generalized myasthenia gravis improve symptoms and daily function compared with placebo.
-
Imeroprubart for adults with CIDP
This study will test whether the monoclonal antibody Imeroprubart helps adults with active CIDP who are already on stable immunoglobulin or corticosteroid treatment.
-
IMVT-1402 as a treatment for adults with Graves' disease
This trial tests whether IMVT-1402 can lower thyroid overactivity in adults with Graves' disease who remain hyperthyroid despite antithyroid drugs.
-
Assessing IMVT-1402 for treating Graves' disease in adults
This study is testing a new treatment called IMVT-1402 to see if it can help adults with Graves' disease who still have high thyroid levels despite taking other medications.
Quick answers
How many clinical trials run by Immunovant Sciences GmbH are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 39 countries. The most sites are in Italy (4 trials), Poland (4 trials), Spain (4 trials), United Kingdom (4 trials), United States (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.